D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 91 Citations 29,672 213 World Ranking 1007 National Ranking 609
Medicine D-index 80 Citations 32,166 183 World Ranking 9408 National Ranking 5088

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

Vikas P. Sukhatme mostly deals with Molecular biology, Cancer research, Internal medicine, Cell biology and Endocrinology. His research in Molecular biology intersects with topics in Type XVIII collagen, Endostatin, Zinc finger, EGR1 and Collagen Type XVIII. The various areas that Vikas P. Sukhatme examines in his Cancer research study include Tumor suppressor gene, Tumor progression, Epidermal growth factor and Cytotoxic T cell.

His study ties his expertise on Preeclampsia together with the subject of Internal medicine. His Preeclampsia research includes themes of Proteinuria and Pathogenesis. The Cell biology study combines topics in areas such as Endothelial stem cell, Cell culture, Angiogenesis, Biochemistry and Cell type.

His most cited work include:

  • Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia (3012 citations)
  • Circulating Angiogenic Factors and the Risk of Preeclampsia (2703 citations)
  • Soluble endoglin contributes to the pathogenesis of preeclampsia. (1390 citations)

What are the main themes of his work throughout his whole career to date?

Molecular biology, Cancer research, Internal medicine, Cell biology and Endocrinology are his primary areas of study. His work focuses on many connections between Molecular biology and other disciplines, such as Gene expression, that overlap with his field of interest in Protein kinase C. His studies deal with areas such as Tumor suppressor gene, Cancer and Immunology as well as Cancer research.

Vikas P. Sukhatme has included themes like Oncology and Preeclampsia in his Internal medicine study. The study incorporates disciplines such as Placental growth factor and Immediate early gene in addition to Endocrinology. His Angiogenesis research is multidisciplinary, incorporating elements of Endothelial stem cell and Pharmacology.

He most often published in these fields:

  • Molecular biology (32.13%)
  • Cancer research (24.92%)
  • Internal medicine (22.22%)

What were the highlights of his more recent work (between 2009-2021)?

  • Cancer research (24.92%)
  • Cancer (10.21%)
  • Internal medicine (22.22%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Cancer research, Cancer, Internal medicine, Oncology and Drug repositioning. His Cancer research study incorporates themes from Cell growth, Immunology, Myeloid-derived Suppressor Cell, Proinflammatory cytokine and Tumor progression. His research integrates issues of Protein kinase B, Gene knockdown, Carcinogenesis, Molecular biology and Mitochondrion in his study of Cell growth.

The concepts of his Cancer study are interwoven with issues in Angiogenesis, Macrophage and Immune system. His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine. Vikas P. Sukhatme has researched Endocrinology in several fields, including Pregnancy, Placental growth factor, Vascular endothelial growth factor, Nifedipine and Minoxidil.

Between 2009 and 2021, his most popular works were:

  • Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells (280 citations)
  • Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor initiating cells (266 citations)
  • Modeling precision treatment of breast cancer (209 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Enzyme

Vikas P. Sukhatme focuses on Cancer research, Cancer, Cell growth, Drug repositioning and Glycolysis. His Cancer research research is multidisciplinary, incorporating perspectives in Immunology, Pathology, PI3K/AKT/mTOR pathway, Signal transduction and Myeloid-derived Suppressor Cell. His biological study spans a wide range of topics, including Carcinogenesis, Transmembrane protein, Molecular biology, MUC1 and Mitochondrion.

His Drug repositioning research is multidisciplinary, relying on both Internal medicine and Oncology. His work deals with themes such as Cancer cell and In vivo, which intersect with Glycolysis. His work investigates the relationship between Cisplatin and topics such as Cell culture that intersect with problems in Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Sharon E. Maynard;Jiang Yong Min;Jaime Merchan;Kee Hak Lim.
Journal of Clinical Investigation (2003)

4169 Citations

Circulating Angiogenic Factors and the Risk of Preeclampsia

Richard J. Levine;Sharon E. Maynard;Cong Qian;Kee Hak Lim.
The New England Journal of Medicine (2004)

3748 Citations

Soluble endoglin contributes to the pathogenesis of preeclampsia.

Shivalingappa Venkatesha;Mourad Toporsian;Chun Lam;Jun-ichi Hanai.
Nature Medicine (2006)

2004 Citations

A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization

Vikas P. Sukhatme;Xinmin Cao;Louise C. Chang;Chon-Hwa Tsai-Morris.
Cell (1988)

1384 Citations

Endostatin induces endothelial cell apoptosis.

Mohanraj Dhanabal;Ramani Ramchandran;Matthew J.F. Waterman;Hua Lu.
Journal of Biological Chemistry (1999)

958 Citations

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

Kazushige Hanaoka;Feng Qian;Alessandra Boletta;Anil K. Bhunia.
Nature (2000)

845 Citations

Combined effects of angiostatin and ionizing radiation in antitumour therapy

Helena J. Mauceri;Nader N. Hanna;Michael A. Beckett;David H. Gorski.
Nature (1998)

831 Citations

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

Debabrata Mukhopadhyay;Leonidas Tsiokas;Xiao Mai Zhou;David Foster.
Nature (1995)

724 Citations

Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors.

Andrea Gashler;Vikas P. Sukhatme.
Progress in Nucleic Acid Research and Molecular Biology (1995)

682 Citations

Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

IA Drummond;SL Madden;P Rohwer-Nutter;GI Bell.
Science (1992)

633 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Vikas P. Sukhatme

S. Ananth Karumanchi

S. Ananth Karumanchi

Cedars-Sinai Medical Center

Publications: 206

Roberto Romero

Roberto Romero

National Institutes of Health

Publications: 119

Ralph R. Weichselbaum

Ralph R. Weichselbaum

University of Chicago

Publications: 93

Sonia S. Hassan

Sonia S. Hassan

Wayne State University

Publications: 83

Tinnakorn Chaiworapongsa

Tinnakorn Chaiworapongsa

Wayne State University

Publications: 73

Donald Kufe

Donald Kufe

Harvard University

Publications: 70

Offer Erez

Offer Erez

Ben-Gurion University of the Negev

Publications: 62

Stefan Somlo

Stefan Somlo

Yale University

Publications: 61

Juan Pedro Kusanovic

Juan Pedro Kusanovic

National Institutes of Health

Publications: 58

Vivek M. Rangnekar

Vivek M. Rangnekar

University of Kentucky

Publications: 54

Ravi Thadhani

Ravi Thadhani

Harvard University

Publications: 53

Ralf Dechend

Ralf Dechend

Max Delbrück Center for Molecular Medicine

Publications: 51

Raghu Kalluri

Raghu Kalluri

The University of Texas MD Anderson Cancer Center

Publications: 49

Levon M. Khachigian

Levon M. Khachigian

University of New South Wales

Publications: 48

Joey P. Granger

Joey P. Granger

University of Mississippi Medical Center

Publications: 48

James M. Roberts

James M. Roberts

University of Pittsburgh

Publications: 48

Trending Scientists

Arun Ross

Arun Ross

Michigan State University

Igor Kukavica

Igor Kukavica

University of Southern California

Shirui Pan

Shirui Pan

Griffith University

Kazuo Hotate

Kazuo Hotate

Toyota Technological Institute

Jean-Luc Ravanat

Jean-Luc Ravanat

Grenoble Alpes University

Gabriele M. König

Gabriele M. König

University of Bonn

Aron Kuppermann

Aron Kuppermann

California Institute of Technology

Michael Schaub

Michael Schaub

University of Zurich

Ciarán Condon

Ciarán Condon

Université Paris Cité

Michael P. Kavanaugh

Michael P. Kavanaugh

University of Montana

Frédéric Gaymard

Frédéric Gaymard

University of Montpellier

Asad U. Khan

Asad U. Khan

COMSATS University Islamabad

David R Gray

David R Gray

University of Tasmania

Xinghui Xia

Xinghui Xia

Beijing Normal University

John F. Kelly

John F. Kelly

Harvard University

Dik J. Kwekkeboom

Dik J. Kwekkeboom

Erasmus University Rotterdam

Something went wrong. Please try again later.